Loading...
Derniers dépôts
-
Paul Loubet, Jean-Daniel Lelievre, Alexis Francois, Elisabeth Botelho-Nevers, Christian Chidiac, et al.. Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: a French nationwide multicenter cohort study - ANRS0001s COV-POPART. International Journal of Infectious Diseases, 2024, 146, pp.107110. ⟨10.1016/j.ijid.2024.107110⟩. ⟨hal-04627501⟩
-
Marie Pouquet, Dorine Decarreaux, Laura Di Domenico, Chiara Sabbatini, Pol Prévot-Monsacre, et al.. SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave. Scientific Reports, 2024, 14 (1), pp.5418. ⟨10.1038/s41598-024-55477-9⟩. ⟨hal-04494616⟩
-
Christel Gérardin. Développement d’un outil d’aide à la décision thérapeutique pour quatre maladies rares : le lupus érythémateux, la sclérodermie systémique, la maladie de Takayasu, le syndrome des anti-phospholipides. Médecine humaine et pathologie. Sorbonne Université, 2023. Français. ⟨NNT : 2023SORUS424⟩. ⟨tel-04615710⟩
-
Elisa Teyssou, Cathia Soulie, Antoine Fauchois, Romain Palich, Agathe Nouchi, et al.. The RT M184V resistance mutation clearance in the reservoir is mainly related to CD4 nadir and viral load zenith independently of therapeutic regimen type. Journal of Antimicrobial Chemotherapy, 2024, Online ahead of print. ⟨10.1093/jac/dkae164⟩. ⟨hal-04610433⟩
-
Charlotte Laniece Delaunay, Aryse Melo, Marine Maurel, Clara Mazagatos, Luise Goerlitz, et al.. Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023–January 2024. Vaccine, 2024, Online ahead of print. ⟨10.1016/j.vaccine.2024.05.067⟩. ⟨hal-04608441⟩
-
Bénédicte Coulm, Delphine Beghin, Mathilde Latour, Bilal Majed, Catherine Vauzelle, et al.. La nouvelle version du site internet du Centre de Référence sur les Agents Tératogènes et ses fonctionnalités optimisées. Gynécologie Obstétrique Fertilité & Sénologie, 2024, ⟨10.1016/j.gofs.2024.05.005⟩. ⟨hal-04607405⟩
-
Rita El Haddad, Adeline Renuy, Emmanuel Wiernik, Maria Melchior, Marie Zins, et al.. Proportion of At-Risk Alcohol Consumers According to the New French Guidelines: Cross-Sectional Weighted Analyses From the CONSTANCES Cohort. International Journal of Public Health, 2024, 69, pp.1606481. ⟨10.3389/ijph.2024.1606481⟩. ⟨hal-04474516⟩
-
Fabrice Bonnet, Beverley Balkau, Oriane Lambert, Yakhara Diawara, Christian Combe, et al.. The number of nephroprotection targets attained is associated with cardiorenal outcomes and mortality in patients with diabetic kidney disease. The CKD‐REIN cohort study. Diabetes, Obesity and Metabolism, 2024, ⟨10.1111/dom.15507⟩. ⟨hal-04484106⟩
-
Rim Bourguiba, Maeva Kyheng, Isabelle Koné-Paut, Diane Rouzaud, Jerome Avouac, et al.. COVID-19 Infection among Patients with Autoinflammatory Diseases: A Study on 117 French Patients Compared with 1545 from the French RMD COVID-19 Cohort: COVIMAI \textendash the French Cohort Study of SARS-CoV-2 Infection in Patient with Systemic Autoinflammatory Diseases. RMD Open : Rheumatic & Musculoskeletal Diseases, 2022, 8 (1), pp.e002063. ⟨10.1136/rmdopen-2021-002063⟩. ⟨hal-04418508⟩